Lalan S. Wilfong
Lalan S. Wilfong publishes mostly in Economics and Econometrics, Oncology and Public Health, Environmental and Occupational Health, on topics such as Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life and Pancreatic and Hepatic Oncology Research.
- World rank
- #2,172,504 of 7,710,434 ranked researchers
- Rank in United States
- #652,971 of 1,627,098
- Works
- 119
- Citations
- 706
- Citations per work
- 5.9
What does Lalan S. Wilfong research?
Lalan S. Wilfong's work is mostly in Economics, Econometrics and Finance (39%), Medicine (30%), Health Professions (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Social Sciences4638.9%
- Health Sciences4336.3%
- Medicine3630.0%
- Health Professions76.3%
- Everything else3024.8%
- 1Economics and Econometrics39% of their works
- 2Oncology16% of their works
- 3Public Health, Environmental and Occupational Health8% of their works
- 4General Health Professions6% of their works
- 5Surgery3% of their works
- 6Pulmonary and Respiratory Medicine3% of their works
Research topics
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Pancreatic and Hepatic Oncology Research
- Pharmaceutical Economics and Policy
- Palliative Care and End-of-Life Issues
- Cancer Genomics and Diagnostics
- Biosimilars and Bioanalytical Methods
- Primary Care and Health Outcomes
Which keywords describe Lalan S. Wilfong's research?
The keywords of their largest research topics: Cost of Care, Financial Toxicity, Cost-effectiveness Analysis, Quality of Life, Pancreatic Cancer, Surgical Complications, Drug Development Costs and Generic Drugs.
- Quality Improvement
- Mutational Signatures
- Cancer Genomics
- Palliative Care
- Generic Drugs
- Surgical Complications
- Quality of Life
- Financial Toxicity
- Cost of Care
- Cost-effectiveness Analysis
- Pancreatic Cancer
- Drug Development Costs
- End-of-Life
- Biosimilars
- Immunogenicity
- Primary Care
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Cost of Care591 topic
- Financial Toxicity591 topic
- Cost-effectiveness Analysis421 topic
- Quality of Life421 topic
- Pancreatic Cancer151 topic
- Surgical Complications151 topic
- Drug Development Costs131 topic
- Generic Drugs131 topic
- End-of-Life121 topic
- Palliative Care121 topic
- Biosimilars81 topic
- Cancer Genomics81 topic
- Immunogenicity81 topic
- Mutational Signatures81 topic
- Primary Care61 topic
- Quality Improvement61 topic
Where does Lalan S. Wilfong work?
Lalan S. Wilfong's main affiliation in the publication record is The US Oncology Network, United States.
How many publications and citations does Lalan S. Wilfong have?
OpenAlex counts 119 works and 706 citations for Lalan S. Wilfong, an h-index of 13, ranking #2,172,504 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lalan S. Wilfong. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.